The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Morberg John D since 2006.
This trader's CIK number is 1345964.
At the time of last reporting, Morberg John D was the Chief Financial Officer of Lifecore Biomedical, Inc. \de\. (stock ticker symbol LFCR).
Also see all insider trading activities at Lifecore Biomedical, Inc. \de\.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | DEIX | 2,000 | $27,740 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | LFCR | 0 | $0 | 0 | $0 | 17,500 | $0 |
| 2021 | LFCR | 17,400 | $193,412 | 0 | $0 | 0 | $0 |
1. Directed Electronics, Inc. (DEIX)
2. Lifecore Biomedical, Inc. \de\ (LFCR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-06-02 | DEIX | Buy | 200 | 13.38 | 2,676 |
| 2006-05-31 | DEIX | Buy | 1,000 | 13.85 | 13,850 |
| 2006-05-30 | DEIX | Buy | 200 | 13.71 | 2,742 |
| 2006-05-26 | DEIX | Buy | 200 | 13.96 | 2,792 |
| 2006-05-24 | DEIX | Buy | 200 | 14.05 | 2,810 |
| 2006-05-23 | DEIX | Buy | 200 | 14.35 | 2,870 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-18 | LFCR | Option Ex | 17,500 | .00 | 0 |
| 2021-04-19 | LNDC | Buy | 2,000 | 11.05 | 22,100 |
| 2021-04-15 | LNDC | Buy | 2,000 | 10.98 | 21,960 |
| 2021-04-14 | LNDC | Buy | 2,000 | 10.64 | 21,280 |
| 2021-04-13 | LNDC | Buy | 2,000 | 10.18 | 20,360 |
| 2021-02-11 | LNDC | Buy | 1,400 | 11.88 | 16,632 |
| 2021-02-10 | LNDC | Buy | 2,000 | 11.64 | 23,280 |
| 2021-02-09 | LNDC | Buy | 2,000 | 12.06 | 24,120 |
| 2021-02-08 | LNDC | Buy | 2,000 | 10.97 | 21,940 |
| 2021-02-05 | LNDC | Buy | 2,000 | 10.87 | 21,740 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Morberg John D (Chief Financial Officer of Lifecore Biomedical, Inc. \de\ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.